In vitro and in vivo experiments have demonstrated that CAFs promote tumor progression of low tumorigenic prostate adenocarcinoma cells, sustaining their growth and leading to castration resistance and eventually bone metastasis [18,19]. Here, TBX1 is linked to neoplasm.